Clinical Trials Logo

Stroke clinical trials

View clinical trials related to Stroke.

Filter by:

NCT ID: NCT03777631 Active, not recruiting - Ischemic Stroke Clinical Trials

STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study

STABLED
Start date: April 1, 2018
Phase: Phase 3
Study type: Interventional

Catheter ablation (CA) has been reported to reduce risk of stroke in patients with nonvalvular atrial fibrillation (NVAF) in retrospective studies, but risk and benefit of CA has not been well elucidated in NVAF with recent cerebral infarction in prospective randomized trials.

NCT ID: NCT03776877 Recruiting - Stroke, Acute Clinical Trials

Endovascular Treatment in Ischemic Stroke Follow-up Evaluation

ETIS
Start date: June 26, 2018
Phase:
Study type: Observational [Patient Registry]

Study like register with biomarkers samples for patient experiencing acute ischemic stroke, to assess clinical outcomes and different factors that may affect the clinical outcomes.

NCT ID: NCT03775915 Terminated - Stroke Clinical Trials

Neurofeedback for Stroke Rehabilitation

Start date: February 9, 2018
Phase: N/A
Study type: Interventional

Real-time neurofeedback aims to alter brain activation patterns through online feedback of ongoing brain activity using magnetic resonance imagining (MRI). Stroke survivors will be randomised to receive 3 sessions of real or sham neurofeedback. This study aims to investigate whether: 1) stroke survivors can maintain alterations in brain activity after the feedback is removed, 2) neurofeedback training leads to improvements in movement of the hand and arm, 3) neurofeedback training leads to changes in brain structure and function, 4) variability in response across people can be understood.

NCT ID: NCT03773653 Completed - Clinical trials for Stroke Rehabilitation

Synergistic Bilateral Upper-Limb Stroke Rehabilitation Based on Robotic Priming Technique

Start date: November 12, 2018
Phase: N/A
Study type: Interventional

This comparative efficacy study will be based on a 3-armed controlled trial: bilateral robotic priming combined with bilateral arm training (bilateral RT+BAT), bilateral robotic priming combined with mirror therapy (bilateral RT+MT), and the control intervention (bilateral RT+IOT). The goal of this 4-year project is to provide scientific evidence of the comparative efficacy research of hybrid interventions based on unilateral vs. bilateral approach to upper limb rehabilitation in subacute and chronic stroke.

NCT ID: NCT03772457 Recruiting - Clinical trials for Intracranial Hemorrhages

Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban

Start date: January 18, 2019
Phase:
Study type: Observational

This study was aimed at patients with newly diagnosed stroke / TIA associated with nonvalvular atrial fibrillation. We will observe the effect of early using rivaroxaban anticoagulation on hemorrhagic transformation, and explore the predictive value of multi-mode MRI infarct volume / MMP-9 on hemorrhagic transformation after anticoagulation therapy.

NCT ID: NCT03771872 Terminated - Stroke Clinical Trials

Virtual Prism Adaptation Therapy on Hemispatial Neglect

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect of virtual prism adaptation therapy on hemispatial neglect in chronic stroke patients. This study is the randomized, double-blind, sham-controlled, cross-over design. Total 10 patients will be allocated randomly to either real virtual prism adaptation therapy or sham therapy with the wash-out period of more than 2 weeks. Two sessions (20min/session) per day, for 5days (total 10 sessions) will be provided. Behavioral outcomes will be measured before and after completing a total of 10 sessions therapy.

NCT ID: NCT03770377 Withdrawn - Stroke Clinical Trials

Laryngeal Adaptation for Speech and Swallowing

Start date: August 24, 2018
Phase: N/A
Study type: Interventional

This study will test laryngeal adaptation in speech and swallowing function in healthy adults, in patients with cerebral stroke, and in patients with spinocerebellar ataxia type 6. The findings from this proposal will be the first step toward implementing rehabilitation techniques that help patients to prevent speech and swallowing errors before they occur.

NCT ID: NCT03767894 Completed - Stroke Clinical Trials

MyHand: An Active Hand Orthosis for Stroke Patients

Start date: November 13, 2017
Phase: N/A
Study type: Interventional

This study seeks to explore the efficacy of several control mechanisms for the device and the impact of a device training program on its utility as a neuroprosthetic and training tool for upper limb recovery.

NCT ID: NCT03767842 Recruiting - Stroke, Acute Clinical Trials

Volumetric Impedance to Guide Stroke Response

VIGOR
Start date: July 18, 2018
Phase:
Study type: Observational

Assess the ability of the Visor System to detect hemispheric bioimpedance asymmetry

NCT ID: NCT03767517 Completed - Stroke Clinical Trials

A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders

Start date: August 24, 2020
Phase: N/A
Study type: Interventional

Rural patients with life-limiting illness are at very high risk of not receiving appropriate care due to a lack of health professionals, long distances to treatment centers, and limited palliative care (PC) clinical expertise. Secondly, although culture strongly influences people's response to diagnosis, illness and treatment preferences, culturally-based care models are not currently available for most seriously-ill rural patients and their family caregivers. Lack of sensitivity to cultural differences may compromise PC for minority patients. The purpose of this study is to compare a culturally-based Tele-consult program to usual hospital care to determine whether a culturally-based PC Tele-consult program leads to lower symptom burden in hospitalized African American and White older adults with a life-limiting illness.